Patent directory · USPTO A61K / A61P
Patents matching “PTC THERAPEUTICS, INC.”
149 pharma patents match "PTC THERAPEUTICS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 149 pharmaceutical patents matching "PTC THERAPEUTICS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11407753
Compounds for treating Huntington's disease
granted -
US 11395822
Methods for treating Huntington's disease
granted -
US 11390588
2-substituted amino-naphth (1,2-d) imidazol-5-one compounds of pharmaceutically acceptable salts thereof
granted -
US 11382918
Methods for treating Huntington's Disease
granted -
US 11304914
Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
granted -
US 11180483
Substituted reverse pyrimidine Bmi-1 inhibitors
granted -
US 11174212
2,3,5-trimelthyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders
granted -
US 11083737
Methods of administering deflazacort therapy
granted -
US 11021424
Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
granted -
US 10981855
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
granted -
US 10968166
4-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
granted -
US 10959988
Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid for the treatment of disease
granted -
US 10898585
Gene therapy for AADC deficiency
granted -
US 10881658
Methods for treating Huntington's disease
granted -
US 10874672
Methods for treating Huntington's disease
granted -
US 10851101
Compounds for treating spinal muscular atrophy
granted -
US 10849885
Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
granted -
US 10751302
Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
granted -
US 10738014
2-substituted amino-naphth (1,2-d) imidazol-5-one compounds or pharmaceutically acceptable salts thereof
granted -
US 10736857
Treatment of pervasive developmental disorders with redox-active therapeutics
granted -
US 10703701
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
granted -
US 10688099
Methods for modulating the amount of RNA transcripts
granted -
US 10675272
Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease
granted -
US 10668171
Methods for modulating RNA splicing
granted